Resultados de la búsqueda 51-60 of 9595 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...